MedBen Rx
  • About Us
  • Genomic Testing
  • Resources
    • MedBen Rx Blog
    • Online Services & Forms
  • Contact Us
  • MedBen Access
  • MedBen.com
Select Page

Get Total Transparency in Pharmacy Management

Jul 12, 2021 | MedBen Rx, Pharmacy Benefits Manager (PBM), Rx Costs, Savings, Transparency

Lack of disclosure is a common theme for many pharmacy benefit managers (PBMs), be it with employers or state governments. From Benefits Pro: “At least a half-dozen states and the District of Columbia are investigating pharmacy benefit managers, The Wall Street...

Download the 2021 MedBen Client Report Today!

Jun 28, 2021 | Announcements, Client Report, MedBen Rx, Prescription drugs, Rebates, Rx Costs, Rx Spending, Savings

The 2021 MedBen Client Report is now available for download at MedBen.com. In addition to detailing the ways that our clients are spending less on health care, this year’s Client Report highlights the priority MedBen places on client service: Members connect to a...

MedBen Rx Solutions Help Fight Drug Price Hikes

Jun 14, 2021 | Brand Name Drugs, Comparative Effectiveness, MedBen Rx, Prescription drugs, Rx Costs, Savings, Specialty Drugs

The prices of 260 popular brand-name prescription drugs rose 3% from 2019 to 2020 – twice as much as the 1.3% rate of inflation during the same period, according to a new AARP report. Their analysis also found that over the past 15 years, prices of 65 common brands...

MedBen Rx Clients are Saving More. Why?

Jun 1, 2021 | Formularies, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription drugs, Savings, Transparency

MedBen Rx clients save 21.6% when switching from traditional PBMs. What accounts for such a substantial difference? With MedBen Rx you pay what the pharmacy pays – we use the drug’s acquisition cost as a baseline to reduce your costs. MedBen Rx offers total...

Rx Plans Focusing on Best Outcomes Also Deliver Healthier Bottom Line

May 17, 2021 | Comparative Effectiveness, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription drugs, Savings

MedBen Rx clients can save between 10-30% by using comparative effectiveness focusing on the best drug outcomes. One way it does this is by dispelling the costly misperception that “new is better.” “A new FDA approved drug doesn’t mean it’s better than existing...

New MedBen Rx Program Reduced Client Diabetic Drug Spend by 77%

Apr 6, 2021 | Case Study, Comparative Effectiveness, Diabetes, MedBen Rx

MedBen Rx Comparative Effectiveness uses evidence-based research to make sure your members are taking the most effective drugs at the best cost. A MedBen Rx client recently changed their formulary by using Comparative Effectiveness to focus on drugs that would produce...
« Older Entries
Next Entries »

Categories

  • 340B
  • Access solution
  • Access solutions
  • Acquisition Cost Index (ACI)
  • Affordable Care Act
  • Anniversaries
  • Announcements
  • Appropriateness Solutions
  • Avande
  • Average Wholesale Price
  • Benefits Advisory Conference
  • Benefits preservation
  • Biologics
  • Biosimilar
  • Brand Name Drugs
  • Brian Fargus
  • Cancer
  • Caroline Fraker
  • Case Study
  • Cholesterol
  • Claims
  • Client Report
  • Comparative Effectiveness
  • Compliance
  • Consolidated Appropriations Act of 2021 (CAA)
  • Cost Plus
  • Cost Plus Pricing
  • Cost projections
  • Cost Savings
  • Diabetes
  • Discounts
  • Doug Freeman
  • Drug costs
  • Drug makers
  • Drug marketing
  • Drug reimportation
  • Evidence-based research
  • Federal Trade Commission (FTC)
  • Food and Drug Administration (FDA)
  • Formularies
  • Fraud
  • Gene therapy
  • Generic Drugs
  • Genetic testing
  • Genomics
  • GLP-1s
  • Government
  • Guarantees
  • Health and Human Services
  • Health systems
  • Heart medications
  • History
  • Humalog
  • Humira
  • Idacio
  • Inflation
  • Kurt Harden
  • Lawsuits
  • Legislation
  • Limited Use HRA
  • Lobbying
  • Luke Burchard
  • MDMA (ecstasy)
  • MedBen
  • MedBen Access
  • MedBen Basics
  • MedBen Board of Directors\
  • MedBen employees
  • MedBen Rx
  • MedBen Rx Advocate
  • MedBen Rx Alliance
  • MedBen Rx News
  • MedBen University
  • Medicare
  • Mobile app
  • Mounjaro
  • News
  • Nutrigenomics
  • Online Services
  • Opinions
  • Outcomes
  • Overprescribing
  • Own Use
  • Ozempic
  • Patient advocacy program
  • Perigon Pharmacy 360
  • Pharmacies
  • Pharmacogenomics
  • Pharmacy Benefits Manager (PBM)
  • Pharmacy Services Administrator (PSA)
  • Precision medicine
  • Prescription drugs
  • Prescription Portal
  • Pricing solutions
  • Psychedelic drugs
  • Rebates
  • Regulatory
  • Reporting
  • Research
  • Rx Advertising
  • Rx Costs
  • Rx Facts
  • Rx prices
  • Rx Spending
  • RxDC report
  • Savings
  • Specialty Drugs
  • Spread Pricing
  • Statins
  • Stelara
  • Surveys
  • Transparency
  • Trend
  • TruDataRx
  • Trulicity
  • Value
  • Ventegra
  • Wegovy
  • Weight loss
  • Weight loss drugs
  • Weight management
  • Wellness
  • White paper
  • Zepbound
  • About Us
  • Contact Us
  • Blog
  • Online Services
  • MedBen Access
  • Sitemap
  • Privacy
  • MedBen.com

Sign Up for our Newsletter

  • This field is for validation purposes and should be left unchanged.
© 2025 MedBen Rx. All rights reserved.